{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:07:30Z","timestamp":1792159650380,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.sapharm.2023.10.014","type":"journal-article","created":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T05:25:47Z","timestamp":1698557147000},"page":"209-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Sources of nonmedically used prescription psychotherapeutic drugs using real-world data from adolescents and adults assessed for substance use treatment--2014-2022"],"prefix":"10.1016","volume":"20","author":[{"given":"Xinyi","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taryn Dailey","family":"Govoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Illg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jody L.","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Gery P.","family":"Guy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.sapharm.2023.10.014_bib1","article-title":"Prescription drug misuse: taking a lifespan perspective","volume":"14","author":"Schepis","year":"2020","journal-title":"Subst Abuse Res Treat"},{"key":"10.1016\/j.sapharm.2023.10.014_bib2","series-title":"Prescription Drug Misuse: Epidemiology, Prevention, Identification, and Management","author":"Becker","year":"2015"},{"key":"10.1016\/j.sapharm.2023.10.014_bib3","series-title":"How Can Prescription Drug Misuse Be Prevented?","year":"2023"},{"key":"10.1016\/j.sapharm.2023.10.014_bib4","series-title":"Key Substance Use and Mental Health Indicators in the United States: Results from the 2021 National Survey on Drug Use and Health (HHS Publication No.PEP22-07-01-005, NSDUH Series H-57)","year":"2022"},{"key":"10.1016\/j.sapharm.2023.10.014_bib5","series-title":"Misuse of Prescription Drugs Research Report Overview","year":"2023"},{"key":"10.1016\/j.sapharm.2023.10.014_bib6","series-title":"MMWR. Morbidity and Mortality Weekly Report","first-page":"71","article-title":"Drug overdose deaths among persons aged 10\u201319 Years\u2014United States, july 2019\u2013december 2021","author":"Tanz","year":"2022"},{"issue":"50","key":"10.1016\/j.sapharm.2023.10.014_bib7","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.15585\/mmwr.mm7050e3","article-title":"Trends in and characteristics of drug overdose deaths involving illicitly manufactured fentanyls\u2014United States, 2019\u20132020","volume":"70","author":"O'Donnell","year":"2021","journal-title":"MMWR (Morb Mortal Wkly Rep)"},{"issue":"13","key":"10.1016\/j.sapharm.2023.10.014_bib8","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1177\/1087054720943283","article-title":"Prescription stimulant nonmedical use among adolescents evaluated for substance use disorder treatment (CHAT\u2122)","volume":"25","author":"Vosburg","year":"2021","journal-title":"J Atten Disord"},{"key":"10.1016\/j.sapharm.2023.10.014_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.109160","article-title":"Characteristics of adults reporting illicitly manufactured fentanyl or heroin use or prescription opioid misuse in the United States, 2019","volume":"229","author":"Jiang","year":"2021","journal-title":"Drug Alcohol Depend"},{"issue":"23","key":"10.1016\/j.sapharm.2023.10.014_bib10","doi-asserted-by":"crossref","first-page":"749","DOI":"10.15585\/mmwr.mm7123a1","article-title":"Characteristics of adults Aged\u2265 18 Years evaluated for substance use and treatment planning\u2014United States, 2019","volume":"71","author":"Kacha-Ochana","year":"2022","journal-title":"MMWR (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.sapharm.2023.10.014_bib11","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1007\/s11606-019-05559-6","article-title":"Heterogeneity in prescription opioid pain reliever misuse across age groups: 2015\u20132017 national survey on drug use and health","volume":"35","author":"Schuler","year":"2020","journal-title":"J Gen Intern Med"},{"issue":"11","key":"10.1016\/j.sapharm.2023.10.014_bib12","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1080\/10826084.2019.1613434","article-title":"Prescription tranquilizer\/sedative sources for misuse in older adults","volume":"54","author":"Schepis","year":"2019","journal-title":"Subst Use Misuse"},{"issue":"6","key":"10.1016\/j.sapharm.2023.10.014_bib13","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1080\/10826084.2020.1713818","article-title":"Sources of misused prescription opioids and their association with prescription opioid use disorder in the United States: sex and age differences","volume":"55","author":"Park","year":"2020","journal-title":"Subst Use Misuse"},{"issue":"8","key":"10.1016\/j.sapharm.2023.10.014_bib14","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1097\/j.pain.0000000000001241","article-title":"Sources of opioid medication for misuse in older adults: results from a nationally representative survey","volume":"159","author":"Schepis","year":"2018","journal-title":"Pain"},{"issue":"7","key":"10.1016\/j.sapharm.2023.10.014_bib15","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1080\/10826084.2023.2191697","article-title":"Trends in the source of prescription drugs for misuse between 2015 and 2019","volume":"58","author":"Purser","year":"2023","journal-title":"Subst Use Misuse"},{"issue":"11","key":"10.1016\/j.sapharm.2023.10.014_bib16","doi-asserted-by":"crossref","first-page":"298","DOI":"10.15585\/mmwr.mm6911a5","article-title":"Variation in adult outpatient opioid prescription dispensing by age and sex\u2014United States, 2008\u20132018","volume":"69","author":"Schieber","year":"2020","journal-title":"MMWR (Morb Mortal Wkly Rep)"},{"issue":"10","key":"10.1016\/j.sapharm.2023.10.014_bib17","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1001\/jamapediatrics.2023.2376","article-title":"Out-of-Pocket costs and payer types for buprenorphine among US youth aged 12 to 19 years","volume":"177","author":"Terranella","year":"2023","journal-title":"JAMA Pediatr"},{"issue":"2","key":"10.1016\/j.sapharm.2023.10.014_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.54590","article-title":"Trends in out-of-pocket costs for and characteristics of pharmacy-dispensed buprenorphine medications for opioid use disorder treatment by type of payer, 2015 to 2020","volume":"6","author":"Strahan","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"8","key":"10.1016\/j.sapharm.2023.10.014_bib19","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1176\/appi.ajp.2018.17091048","article-title":"Prevalence and correlates of prescription stimulant use, misuse, use disorders, and motivations for misuse among adults in the United States","volume":"175","author":"Compton","year":"2018","journal-title":"Am J Psychiatr"},{"key":"10.1016\/j.sapharm.2023.10.014_bib20","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ypmed.2019.02.018","article-title":"Prescription opioid misuse among middle-aged and older adults in the United States, 2015\u20132016","volume":"121","author":"Han","year":"2019","journal-title":"Prev Med"},{"issue":"1","key":"10.1016\/j.sapharm.2023.10.014_bib21","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/gps.4999","article-title":"Prescription opioid and benzodiazepine misuse is associated with suicidal ideation in older adults","volume":"34","author":"Schepis","year":"2019","journal-title":"Int J Geriatr Psychiatr"},{"issue":"3","key":"10.1016\/j.sapharm.2023.10.014_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain\u2014United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"key":"10.1016\/j.sapharm.2023.10.014_bib23","unstructured":"Spencer MR, Mini\u00f1o AM, Warner M. Drug overdose deaths in the United States, 2001\u20132021. NCHS data brief, 457, pp.1-8.."},{"issue":"455","key":"10.1016\/j.sapharm.2023.10.014_bib24","first-page":"1","article-title":"Drug overdose deaths in adults aged 65 and over: United States, 2000-2020","author":"Kramarow","year":"2022","journal-title":"NCHS data brief"},{"key":"10.1016\/j.sapharm.2023.10.014_bib25","year":"2020"},{"key":"10.1016\/j.sapharm.2023.10.014_bib26","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.drugalcdep.2018.02.010","article-title":"The source and diversion of pharmaceutical drugs for non-medical use: a systematic review and meta-analysis","volume":"186","author":"Hulme","year":"2018","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.sapharm.2023.10.014_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107837","article-title":"Characterization of diverted buprenorphine use among adults entering corrections-based drug treatment in Kentucky","volume":"208","author":"Smith","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"10.1016\/j.sapharm.2023.10.014_bib28","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/10826084.2023.2177972","article-title":"Scope of, motivations for, and outcomes associated with buprenorphine diversion in the United States: a scoping review","volume":"58","author":"Rubel","year":"2023","journal-title":"Subst Use Misuse"},{"issue":"1","key":"10.1016\/j.sapharm.2023.10.014_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-019-0301-y","article-title":"Non-prescribed use of methadone and buprenorphine prior to opioid substitution treatment: lifetime prevalence, motives, and drug sources among people with opioid dependence in five Swedish cities","volume":"16","author":"Johnson","year":"2019","journal-title":"Harm Reduct J"},{"issue":"10","key":"10.1016\/j.sapharm.2023.10.014_bib30","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.29409","article-title":"Trends in and characteristics of buprenorphine misuse among adults in the US","volume":"4","author":"Han","year":"2021","journal-title":"JAMA Netw Open"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741123004667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741123004667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:32:23Z","timestamp":1761557543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741123004667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1551741123004667"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2023.10.014","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sources of nonmedically used prescription psychotherapeutic drugs using real-world data from adolescents and adults assessed for substance use treatment--2014-2022","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2023.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}